{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:00:12Z","timestamp":1793404812048,"version":"4.5.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The immune system protects us from pathogens, such as viruses. Antiviral immune mechanisms aim to limit viral replication, and must maintain immunological homeostasis to avoid excessive inflammation and damage to the host. Sex differences in the manifestation and progression of immune-mediated disease point to sex-specific factors modulating antiviral immunity. The exact mechanisms regulating these immunological differences between females and males are still insufficiently understood. Females are known to display stronger Type I IFN responses and are less susceptible to viral infections compared to males, indicating that Type I IFN responses might contribute to the sexual dimorphisms observed in antiviral responses. Here, we review the impact of sex hormones and X chromosome-encoded genes on differences in Type I IFN responses between females and males; and discuss the consequences of sex differences in Type I IFN responses for the regulation of antiviral immune responses.<\/jats:p>","DOI":"10.3389\/fimmu.2022.986840","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:53:39Z","timestamp":1663289619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["Consequences of sex differences in Type I IFN responses for the regulation of antiviral immunity"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria","family":"Pujantell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Altfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. i. the interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc London Ser B - Biol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1957.0049","article-title":"Virus interference. II. some properties of interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc London Ser B - Biol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: Immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: The biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ra50","DOI":"10.1126\/scisignal.2004998","article-title":"Multifaceted activities of type I interferon are revealed by a receptor antagonist","volume":"7","author":"Levin","year":"2014","journal-title":"Sci Signal"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710907105","article-title":"Role of the akt pathway in mRNA translation of interferon-stimulated genes","volume":"105","author":"Kaur","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-013-3021-1","article-title":"Distinct evolution process among type I interferon in mammals","volume":"4","author":"Xu","year":"2013","journal-title":"Protein Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00209","article-title":"Evolution of interferons and interferon receptors","volume":"8","author":"Secombes","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (\u03b1\/\u03b2) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.12.006","article-title":"Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use","volume":"26","author":"Antonelli","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.07.005","article-title":"The role of differential expression of human interferon-a genes in antiviral immunity","volume":"20","author":"G\u00e9nin","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-i- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2018.10.003","article-title":"Transcriptional and chromatin regulation in interferon and innate antiviral gene expression","volume":"44","author":"Au-Yeung","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2144\/oct0207","article-title":"Signal transduction by type I interferons","volume":"33","author":"David","year":"2002","journal-title":"Biotechniques"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059307","article-title":"The differential antiviral activities of chicken interferon \u03b1 (ChIFN-\u03b1) and ChIFN-\u03b2 are related to distinct interferon-stimulated gene expression","volume":"8","author":"Qu","year":"2013","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.74","article-title":"Distinct antiviral activities of IFN-\u03b1 subtypes","volume":"3","author":"Gibbert","year":"2011","journal-title":"Immunotherapy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000003111","article-title":"Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice","volume":"36","author":"Rout","year":"2022","journal-title":"AIDS"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101299","DOI":"10.1016\/j.smim.2019.101299","article-title":"Interferon signaling in cancer. non-canonical pathways and control of intracellular immune checkpoints","volume":"43","author":"Saleiro","year":"2019","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.606456","article-title":"Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways","volume":"11","author":"Mazewski","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02129","article-title":"Interferon-\u03b1 up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p38 signaling","volume":"9","author":"Bazhin","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.780","article-title":"The PI3\u2032 kinase pathway in interferon signaling","volume":"25","author":"Kaur","year":"2005","journal-title":"J Interf Cytokine Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.14.6258","article-title":"Akt and mRNA translation by interferons","volume":"7","author":"Kaur","year":"2008","journal-title":"Cell Cycle"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118122109","article-title":"Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses","volume":"109","author":"Kaur","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720431115","article-title":"Cyclin-dependent kinase activity is required for type i interferon production","volume":"115","author":"Cing\u00f6z","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201694834","article-title":"Negative regulation of type I IFN signaling by phosphorylation of STAT 2 on T387","volume":"36","author":"Wang","year":"2017","journal-title":"EMBO J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0603255","article-title":"Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells","volume":"74","author":"Izaguirre","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-015354","article-title":"Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells","volume":"109","author":"Vremec","year":"2007","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.4.2088","article-title":"TLR7 ligands induce higher IFN-\u03b1 production in females","volume":"177","author":"Bergh\u00f6fer","year":"2006","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303400","article-title":"X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-\u03b1 production of plasmacytoid dendritic cells from women","volume":"193","author":"Laffont","year":"2014","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501684","article-title":"Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN- production in women","volume":"195","author":"Griesbeck","year":"2015","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756262","article-title":"Why females do better: The X chromosomal TLR7 gene-dose effect in COVID-19","volume":"12","author":"Spiering","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3551","article-title":"Development of subtype-selective oestrogen receptor-based therapeutics","volume":"10","author":"Nilsson","year":"2011","journal-title":"Nat Rev Drug Discovery"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236935","article-title":"Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4","volume":"115","author":"Carreras","year":"2010","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.6.3661","article-title":"Estrogen receptor \u03b1, but not \u03b2, is required for optimal dendritic cell differentiation and CD40-induced cytokine production","volume":"180","author":"Douin-Echinard","year":"2008","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v95.9.2875.009k12_2875_2882","article-title":"Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells","volume":"95","author":"Komi","year":"2000","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2012.04.011","article-title":"Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: Mechanisms and implications for immunity","volume":"62","author":"Kovats","year":"2012","journal-title":"Horm Behav"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00108","article-title":"Estrogen receptor-dependent regulation of dendritic cell development and function","volume":"8","author":"Laffont","year":"2017","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03167","article-title":"Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration","volume":"10","author":"Webb","year":"2019","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-13-35","article-title":"Plasmacytoid dendritic cell interferon-\u03b1 production to r-848 stimulation is decreased in male infants","volume":"13","author":"Wang","year":"2012","journal-title":"BMC Immunol"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-374984-0.01650-8","article-title":"X Chromosome","volume-title":"Brenner\u2019s encyclopedia of genetics","author":"Schwartz","year":"2013"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nri2394","article-title":"The X-files in immunity: Sex-based differences predispose immune responses","volume":"8","author":"Fish","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: When a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/bies.201100047","article-title":"X-Chromosome-located microRNAs in immunity: Might they explain male\/female differences","volume":"33","author":"Pinheiro","year":"2011","journal-title":"BioEssays"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008333","article-title":"Xist RNA in action: Past, present, and future","volume":"15","author":"Loda","year":"2019","journal-title":"PloS Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cels.2015.06.003","article-title":"Individuality and variation of personal regulomes in primary human T cells","volume":"1","author":"Qu","year":"2015","journal-title":"Cell Syst"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01541-18","article-title":"Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8 + T cells","volume":"93","author":"Kwaa","year":"2018","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802889115","article-title":"Sex-chromosome dosage effects on gene expression in humans","volume":"115","author":"Raznahan","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature03479","article-title":"X-Inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108485","article-title":"Heterogeneous escape from X chromosome inactivation results in sex differences in type I IFN responses at the single human pDC level","volume":"33","author":"Hagen","year":"2020","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007050","article-title":"Loss of xist RNA from the inactive X during b cell development is restored in a dynamic YY1-dependent two-step process in activated b cells","volume":"13","author":"Syrett","year":"2017","journal-title":"PloS Genet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2006.07.016","article-title":"X Chromosome gene expression in human tissues: Male and female comparisons","volume":"88","author":"Talebizadeh","year":"2006","journal-title":"Genomics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2015.1084462","article-title":"Integrative analysis of methylome and transcriptome in human blood identifies extensive sex- and immune cell-specific differentially methylated regions","volume":"10","author":"Mamrut","year":"2015","journal-title":"Epigenetics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tig.2011.10.004","article-title":"The end of gonad-centric sex determination in mammals","volume":"28","author":"Arnold","year":"2012","journal-title":"Trends Genet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0421-x","article-title":"Decoding type I and III interferon signalling during viral infection","volume":"4","author":"Mesev","year":"2019","journal-title":"Nat Microbiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4829","article-title":"Relationship between sex hormones and RIG-I signaling in peripheral blood mononuclear cells of patients infected with hepatitis c virus","volume":"14","author":"Wang","year":"2017","journal-title":"Exp Ther Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280b0774a","article-title":"Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART","volume":"21","author":"Collazos","year":"2007","journal-title":"AIDS"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200304010-00017","article-title":"Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The gender issue revisited","volume":"32","author":"Moore","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-virology-091919-092720","article-title":"Sex differences in respiratory viral pathogenesis and treatments","volume":"8","author":"Ursin","year":"2021","journal-title":"Annu Rev Virol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720952","article-title":"Sex differences in immunity to viral infections","volume":"12","author":"Jacobsen","year":"2021","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107795","article-title":"Sex differences in gene expression and regulatory networks across 29 human tissues","volume":"31","author":"Lopes-Ramos","year":"2020","journal-title":"Cell Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-4666(03)00226-6","article-title":"IFN\u03b1 regulates NK cell cytotoxicity through STAT1 pathway","volume":"23","author":"Liang","year":"2003","journal-title":"Cytokine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111302","article-title":"Role of type I interferon receptor signaling on NK cell development and functions","volume":"9","author":"Guan","year":"2014","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21284","article-title":"Conditional IFNAR1 ablation reveals distinct requirements of type I IFN signaling for NK cell maturation and tumor surveillance","volume":"1","author":"Mizutani","year":"2012","journal-title":"Oncoimmunology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00937","article-title":"IFNAR2 deficiency causing dysregulation of NK cell functions and presenting with hemophagocytic lymphohistiocytosis","volume":"11","author":"Passarelli","year":"2020","journal-title":"Front Genet"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091573","article-title":"Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation","volume":"207","author":"Ebihara","year":"2010","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: A lesson in d\u00e9tente","volume":"312","author":"Garc\u00eda-Sastre","year":"2006","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2006.05.025","article-title":"STAT1 acts as a tumor promoter for leukemia development","volume":"10","author":"Kovacic","year":"2006","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct requirements for IFNs and STAT1 in NK cell function","volume":"165","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/jci22315","article-title":"TYK2 is a key regulator of the surveillance of b lymphoid tumors","volume":"114","author":"Stoiber","year":"2004","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055694","article-title":"Testosterone increases susceptibility to amebic liver abscess in mice and mediates inhibition of IFN\u03b3 secretion in natural killer T cells","volume":"8","author":"Lotter","year":"2013","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E","article-title":"Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: From birth to adulthood","volume":"26","author":"Lee","year":"1996","journal-title":"Commun Clin Cytom"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023216118","article-title":"Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis","volume":"118","author":"Huang","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2011.10.009","article-title":"Gender effect on in vitro lymphocyte subset levels of healthy individuals","volume":"272","author":"Abdullah","year":"2012","journal-title":"Cell Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mad.2016.04.001","article-title":"The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men","volume":"156","author":"Al-Attar","year":"2016","journal-title":"Mech Ageing Dev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6153","article-title":"The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells","volume":"81","author":"Yovel","year":"2001","journal-title":"Gynecol Oncol"},{"key":"B90","article-title":"Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients","volume":"41","author":"Nagel","year":"1981","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.22.195","article-title":"Natural killer cell activity associated with aging and sex in humans","volume":"22","author":"Sugiyama","year":"1983","journal-title":"Jpn J Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5746","article-title":"NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis","volume":"180","author":"Arruvito","year":"2008","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0378(00)00091-7","article-title":"Influence of menstrual cycle on NK activity","volume":"50","author":"Souza","year":"2001","journal-title":"J Reprod Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00384.x","article-title":"Programming, demarcating, and manipulating CD8 + T-cell memory","volume":"211","author":"Badovinac","year":"2006","journal-title":"Immunol Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00025","article-title":"Balancing immune protection and immune pathology by CD8+ T-cell responses to influenza infection","volume":"7","author":"Duan","year":"2016","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T cell response to respiratory virus infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J Exp Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02255","article-title":"Diverse immunomodulatory effects of individual IFN\u03b1 subtypes on virus-specific CD8+ T cell responses","volume":"10","author":"Dickow","year":"2019","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type i interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110071","article-title":"Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex","volume":"37","author":"Poon","year":"2021","journal-title":"Cell Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1800066","article-title":"Differential sensitivity to IL-12 drives sex-specific differences in the CD8 + T cell response to infection","volume":"3","author":"Yee Mon","year":"2019","journal-title":"ImmunoHorizons"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130901","article-title":"IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo","volume":"211","author":"Starbeck-Miller","year":"2014","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986840\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:53:44Z","timestamp":1663289624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986840\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2022.986840"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.986840","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"986840"}}